Effectiveness and short-term (16-week) tolerance of guselkumab for psoriasis under real-life conditions: a retrospective multicenter study

J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e644-e646. doi: 10.1111/jdv.16511. Epub 2020 May 25.
No abstract available

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Antibodies, Monoclonal, Humanized*
  • Humans
  • Psoriasis* / drug therapy
  • Retrospective Studies

Substances

  • Antibodies, Monoclonal, Humanized
  • guselkumab